• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊普通外科中的源头控制:WSES、GAIS、SIS-E、SIS-A 指南。

Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines.

机构信息

General, Emergency and Trauma Surgery Dept., Pisa University Hospital, Via Paradisia, 56124, Pisa, Italy.

General Surgery Dept., Macerata Hospital, Macerata, Italy.

出版信息

World J Emerg Surg. 2023 Jul 21;18(1):41. doi: 10.1186/s13017-023-00509-4.

DOI:10.1186/s13017-023-00509-4
PMID:37480129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10362628/
Abstract

Intra-abdominal infections (IAI) are among the most common global healthcare challenges and they are usually precipitated by disruption to the gastrointestinal (GI) tract. Their successful management typically requires intensive resource utilization, and despite the best therapies, morbidity and mortality remain high. One of the main issues required to appropriately treat IAI that differs from the other etiologies of sepsis is the frequent requirement to provide physical source control. Fortunately, dramatic advances have been made in this aspect of treatment. Historically, source control was left to surgeons only. With new technologies non-surgical less invasive interventional procedures have been introduced. Alternatively, in addition to formal surgery open abdomen techniques have long been proposed as aiding source control in severe intra-abdominal sepsis. It is ironic that while a lack or even delay regarding source control clearly associates with death, it is a concept that remains poorly described. For example, no conclusive definition of source control technique or even adequacy has been universally accepted. Practically, source control involves a complex definition encompassing several factors including the causative event, source of infection bacteria, local bacterial flora, patient condition, and his/her eventual comorbidities. With greater understanding of the systemic pathobiology of sepsis and the profound implications of the human microbiome, adequate source control is no longer only a surgical issue but one that requires a multidisciplinary, multimodality approach. Thus, while any breach in the GI tract must be controlled, source control should also attempt to control the generation and propagation of the systemic biomediators and dysbiotic influences on the microbiome that perpetuate multi-system organ failure and death. Given these increased complexities, the present paper represents the current opinions and recommendations for future research of the World Society of Emergency Surgery, of the Global Alliance for Infections in Surgery of Surgical Infection Society Europe and Surgical Infection Society America regarding the concepts and operational adequacy of source control in intra-abdominal infections.

摘要

腹腔内感染 (IAI) 是全球最常见的医疗保健挑战之一,通常由胃肠道 (GI) 道破裂引起。成功治疗此类感染通常需要大量资源,尽管采用了最佳疗法,发病率和死亡率仍然很高。与其他败血症病因不同,IAI 治疗的一个主要问题是需要经常进行物理源控制。幸运的是,在这方面的治疗已经取得了显著进展。从历史上看,源控制仅由外科医生负责。随着新技术的出现,已经引入了非手术微创介入程序。或者,除了正式手术外,开放性腹部技术也长期以来被提议作为严重腹腔内败血症源控制的辅助手段。具有讽刺意味的是,尽管缺乏甚至延迟源控制显然与死亡相关,但这一概念仍未得到充分描述。例如,源控制技术甚至充足性的明确定义尚未被普遍接受。实际上,源控制涉及一个复杂的定义,包括几个因素,包括致病事件、感染源细菌、局部细菌菌群、患者状况及其最终合并症。随着对败血症系统病理生物学的深入了解以及人类微生物组的深远影响,充分的源控制不再仅仅是一个外科问题,而是需要多学科、多模式的方法。因此,虽然必须控制任何 GI 道的破裂,但源控制还应尝试控制全身性生物介质的产生和传播,以及对微生物组的失调影响,这些因素会导致多系统器官衰竭和死亡。鉴于这些复杂性的增加,本文代表了世界急诊外科学会、外科感染学会欧洲全球感染联盟和美国外科感染学会对腹腔内感染源控制概念和操作充足性的当前意见和未来研究建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/4e9322b0828e/13017_2023_509_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/4eef794f63a3/13017_2023_509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/5d90dfa5fded/13017_2023_509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/296b33004cec/13017_2023_509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/c2d1ee375751/13017_2023_509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/b4319679c89c/13017_2023_509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/6e71d31abc83/13017_2023_509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/01872a333144/13017_2023_509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/db53973ddfa5/13017_2023_509_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/4e9322b0828e/13017_2023_509_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/4eef794f63a3/13017_2023_509_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/5d90dfa5fded/13017_2023_509_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/296b33004cec/13017_2023_509_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/c2d1ee375751/13017_2023_509_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/b4319679c89c/13017_2023_509_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/6e71d31abc83/13017_2023_509_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/01872a333144/13017_2023_509_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/db53973ddfa5/13017_2023_509_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d38/10362628/4e9322b0828e/13017_2023_509_Fig9_HTML.jpg

相似文献

1
Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines.急诊普通外科中的源头控制:WSES、GAIS、SIS-E、SIS-A 指南。
World J Emerg Surg. 2023 Jul 21;18(1):41. doi: 10.1186/s13017-023-00509-4.
2
[Interpretation of the World Society of the Emergency Surgery/the Global Alliance for Infection in Surgery/the Surgical Infection Society-Europe/the World Surgical Infection Society/the American Association for the Surgery of Trauma global clinical pathways for patients with intra-abdominal infections].[世界急诊外科学会/全球外科感染联盟/欧洲外科感染学会/世界外科感染学会/美国创伤外科学会关于腹腔内感染患者的全球临床路径解读]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):229-237. doi: 10.3760/cma.j.cn121430-20220927-00867.
3
[Interpretation of acute abdomen in the immunocompromised patients: WSES/SIS-E/WSIS/AAST/GAIS guideline].[免疫功能低下患者急腹症的解读:WSES/SIS-E/WSIS/AAST/GAIS指南]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Mar;34(3):239-244. doi: 10.3760/cma.j.cn121430-20211008-01440.
4
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections.WSES/GAIS/SIS-E/WSIS/AAST 全球腹腔内感染患者临床路径。
World J Emerg Surg. 2021 Sep 25;16(1):49. doi: 10.1186/s13017-021-00387-8.
5
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
6
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines.免疫功能低下患者的急腹症:WSES、SIS-E、WSIS、AAST 和 GAIS 指南。
World J Emerg Surg. 2021 Aug 9;16(1):40. doi: 10.1186/s13017-021-00380-1.
7
Declaration on infection prevention and management in global surgery.全球手术感染预防与管理宣言
World J Emerg Surg. 2023 Dec 6;18(1):56. doi: 10.1186/s13017-023-00526-3.
8
The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.从全球视角看腹腔内感染的管理:2017 年 WSES 腹腔内感染管理指南。
World J Emerg Surg. 2017 Jul 10;12:29. doi: 10.1186/s13017-017-0141-6. eCollection 2017.
9
[Surgical rescue strategies and techniques for severe intra-abdominal infection].[严重腹腔内感染的外科救治策略与技术]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Sep 25;26(9):813-817. doi: 10.3760/cma.j.cn441530-20230807-00037.
10
Current progress of source control in the management of intra-abdominal infections.目前在腹腔感染管理中源控制的进展。
Chin J Traumatol. 2020 Dec;23(6):311-313. doi: 10.1016/j.cjtee.2020.07.003. Epub 2020 Aug 3.

引用本文的文献

1
Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research.脓毒症、感染性休克患者或需要入住重症监护病房患者血流感染的源头控制:一项范围综述及标准化研究建议
Intensive Care Med. 2025 Jul 14. doi: 10.1007/s00134-025-08026-5.
2
Unveiling the research advances of sepsis: pathogenesis, precise intervention and clinical perspective.揭示脓毒症的研究进展:发病机制、精准干预及临床展望
Int J Surg. 2025 Jun 23;111(9):6260-89. doi: 10.1097/JS9.0000000000002668.
3
A rare presentation of perforated Meckel diverticulitis in adulthood.

本文引用的文献

1
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.美国传染病学会2023年抗微生物药物耐药革兰氏阴性菌感染治疗指南
Clin Infect Dis. 2023 Jul 18. doi: 10.1093/cid/ciad428.
2
Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI).重新评估头孢吡肟或哌拉西林-他唑巴坦以减少产超广谱β-内酰胺酶肠杆菌科血流感染中碳青霉烯类药物的使用(REDUCE-BSI)。
Antimicrob Steward Healthc Epidemiol. 2022 Mar 11;2(1):e39. doi: 10.1017/ash.2022.21. eCollection 2022.
3
成人梅克尔憩室炎穿孔的罕见表现。
J Surg Case Rep. 2025 May 30;2025(5):rjaf348. doi: 10.1093/jscr/rjaf348. eCollection 2025 May.
4
Vacuum-assisted closure or primary closure with relaparotomy on-demand in patients with secondary peritonitis: a systematic review and meta-analysis.继发性腹膜炎患者采用真空辅助闭合术或按需再次剖腹手术进行一期闭合:一项系统评价和荟萃分析
World J Emerg Surg. 2025 May 22;20(1):42. doi: 10.1186/s13017-025-00615-5.
5
Management of Perforated Appendicitis in Amyand's Hernia: A Multidisciplinary Approach to Complex Postoperative Complications.艾米安德疝合并穿孔性阑尾炎的管理:复杂术后并发症的多学科处理方法
Cureus. 2025 Mar 31;17(3):e81498. doi: 10.7759/cureus.81498. eCollection 2025 Mar.
6
Open abdomen versus primary closure in the management of severe abdominal sepsis: What is the right way? Results of the last 5 years of a reference center.严重腹部脓毒症治疗中开放腹腔与一期缝合:哪种方法正确?一家参考中心过去5年的结果
Langenbecks Arch Surg. 2025 Apr 26;410(1):147. doi: 10.1007/s00423-025-03693-w.
7
Epidemiological analysis of intra-abdominal infections in Italy from the Italian register of complicated intra-abdominal infections-the IRIS study: a prospective observational nationwide study.来自意大利复杂性腹腔内感染登记处的意大利腹腔内感染流行病学分析——IRIS研究:一项全国性前瞻性观察研究。
World J Emerg Surg. 2025 Mar 17;20(1):22. doi: 10.1186/s13017-025-00590-x.
8
COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study.新冠病毒感染是急性胆囊炎患者死亡的一个重要风险因素:ChoCO-W队列研究的二次分析
World J Emerg Surg. 2025 Feb 25;20(1):16. doi: 10.1186/s13017-025-00591-w.
9
Evidence-based, cost-effective management of acute appendicitis: An algorithm of the Journal of Trauma and Acute Care Surgery emergency general surgery algorithms work group.基于证据的急性阑尾炎成本效益管理:创伤与急性病外科杂志急诊普通外科算法工作组的一种算法
J Trauma Acute Care Surg. 2025 Mar 1;98(3):368-373. doi: 10.1097/TA.0000000000004569. Epub 2025 Feb 3.
10
Vacuum-Assisted Closure Significantly Reduces Surgical Postoperative Complications Compared With Primary Abdominal Closure in Patients With Secondary Peritonitis: A Comparative Retrospective Study.与一期腹部缝合相比,负压封闭引流显著降低继发性腹膜炎患者的外科术后并发症:一项比较性回顾性研究。
World J Surg. 2025 Feb;49(2):387-400. doi: 10.1002/wjs.12472. Epub 2025 Jan 10.
Association Between Time to Source Control in Sepsis and 90-Day Mortality.
脓毒症源控制时间与 90 天死亡率的关系。
JAMA Surg. 2022 Sep 1;157(9):817-826. doi: 10.1001/jamasurg.2022.2761.
4
Efficacy and Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens.新型抗生素治疗碳青霉烯类耐药革兰氏阴性菌感染的疗效和活性。
Front Cell Infect Microbiol. 2022 May 20;12:884365. doi: 10.3389/fcimb.2022.884365. eCollection 2022.
5
WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.WSES/GAIS/WSIS/SIS-E/AAST 全球皮肤和软组织感染患者临床路径。
World J Emerg Surg. 2022 Jan 15;17(1):3. doi: 10.1186/s13017-022-00406-2.
6
Timing of antibiotic therapy in the ICU.ICU 中的抗生素治疗时机。
Crit Care. 2021 Oct 15;25(1):360. doi: 10.1186/s13054-021-03787-z.
7
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections.WSES/GAIS/SIS-E/WSIS/AAST 全球腹腔内感染患者临床路径。
World J Emerg Surg. 2021 Sep 25;16(1):49. doi: 10.1186/s13017-021-00387-8.
8
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines.免疫功能低下患者的急腹症:WSES、SIS-E、WSIS、AAST 和 GAIS 指南。
World J Emerg Surg. 2021 Aug 9;16(1):40. doi: 10.1186/s13017-021-00380-1.
9
Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature.免疫功能低下患者手术部位感染的预防与管理:文献系统评价
World J Emerg Surg. 2021 Jun 10;16(1):33. doi: 10.1186/s13017-021-00375-y.
10
Novel Beta-Lactam/Beta-Lactamase Plus Metronidazole vs Carbapenem for Complicated Intra-abdominal Infections: A Meta-analysis of Randomized Controlled Trials.新型β-内酰胺/β-内酰胺酶抑制剂联合甲硝唑与碳青霉烯类治疗复杂性腹腔内感染:一项随机对照试验的荟萃分析
Open Forum Infect Dis. 2020 Dec 8;8(1):ofaa591. doi: 10.1093/ofid/ofaa591. eCollection 2021 Jan.